Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Wacker Chemie (XTRA:WCH) is preparing for investor attention ahead of its September 23 presentation at the Berenberg and Goldman Sachs 15th German Corporate Conference in Munich, where CEO Christian Hartel will outline management’s current priorities. Recent trading has been choppy. Wacker Chemie’s share price return is up 25.9% year to date at €89.95, while the 1 year total shareholder return of 41.1% contrasts with a 3 year total shareholder return that is down 23.8%. This suggests momentum...
Delray Beach, FL, Sept. 28, 2026 (GLOBE NEWSWIRE) -- The global Adhesion Promoter Market is projected to grow from USD 5.97 billion in 2026 to USD 8.32 billion by 2031, registering a CAGR of 6.9% during 2026–2031. Growth is driven by increasing adoption of lightweight plastics, composites, multi-material structures, EVs, advanced coatings, adhesives, and engineered materials. Get PDF Brochure — Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95337354 Key Marke
According to a Reuters report, Washington is preparing to introduce a minimum import price, along with tariffs on polysilicon and related products.
The Trump administration is preparing to set a price floor and impose tariffs on polysilicon and related products, according to four people familiar with the plan, putting a material critical to solar panels and semiconductors at the center of U.S. efforts to compete with China on artificial intelligence and energy. The decision, expected to come later this month, aims to protect U.S. polysilicon factories owned by Hemlock Semiconductor and Wacker Chemie from growing Chinese ambitions in the chip supply chain.
Group sales rose 7% year-over-year to EUR1.52 billion, while EBITDA before special effects surged 53% to EUR175 million, driven by cost savings and better operating performance.
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Pharmaceutical Surfactants Market size & share revenue was valued at approximately USD 4.5 Billion in 2025 and is expected to reach USD 4.69 Billion in 2026 and is expected to reach around USD 6.93 Billion by 2035, at a CAGR of 4.42% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Akzo Nobel N.V., Evonik
The fumed silica market, projected to grow from USD 1.80 billion in 2025 to USD 2.14 billion by 2030 at a CAGR of 3.46%, finds increasing applications in industries like building & construction, automotive, electronics, personal care, and pharmaceuticals. Key growth drivers include performance optimization, lightweighting, and sustainable materials. Hydrophobic fumed silica leads growth due to its superior water resistance and thickening properties. UPR & Composites, and pharmaceuticals are the
SHAH ALAM, MY / ACCESS Newswire / June 10, 2026 / Eckem Holdings Berhad("Eckem Holdings", together with its subsidiaries, the "Group"), a specialty industrial chemical solutions provider in Malaysia, which also undertakes the manufacturing and trading ...
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Specialty Chemicals Market size & share revenue was valued at approximately USD 902 Billion in 2025 and is expected to reach USD 949 Billion in 2026 and is expected to reach around USD 1497 Billion by 2035, at a CAGR of 5.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Lanxess AG, Arkema S.A., Asahi
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Wearable Health Silicone Elastomers Market size & share revenue was valued at approximately USD 1.47 Billion in 2025 and is expected to reach USD 1.6 Billion in 2026 and is expected to reach around USD 3.44 Billion by 2035, at a CAGR of 8.87% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Dow Inc., Wac
Wacker Chemie is back in focus after a series of analyst revisions lifted a key fair value estimate from €73.50 to about €81.43, alongside a move in at least one bank’s price target to €61 from €59. Supportive analysts link these adjustments to refreshed assumptions and view the cluster of upgrades as a signal that earlier expectations may have been too cautious. More skeptical voices, however, argue the higher targets mainly reflect model tweaks rather than new evidence. As you read on, you...
Despite a 5% revenue decline, Wacker Chemie AG (WKCMF) reports a robust 45% increase in EBITDA, driven by strategic cost-saving initiatives and market positioning.
Wacker Chemie (ETR:WCH) reported what CEO Dr. Christian Hartel described as a “solid start to the year” in the first quarter of 2026, with earnings improving sharply despite weaker demand across many end markets and a year-over-year decline in sales driven largely by currency effects. Group sales i
Despite a challenging year with significant restructuring costs, Wacker Chemie AG (WKCMF) outlines a path to recovery and growth in 2026.
Wacker Chemie (ETR:WCH) reported full-year 2025 sales of EUR 5.5 billion and EBITDA before special items of around EUR 529 million, results that management said were in line with the company’s revised guidance from October. Speaking on the company’s full-year results call, CEO Dr. Christian Hartel s
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.